BHC's fourth-quarter adjusted earnings and revenues beat estimates driven by Xifaxan. The guidance for 2025 is positive.

Ironwood reports weaker-than-expected results for the fourth quarter of 2024. The company maintains total revenue guidance for 2025.

UTHR beats fourth-quarter estimates for both earnings and sales. Tyvaso sales fall short of estimates. Stock down in pre-market trading.

TMDX's fourth-quarter earnings depict strength in the company's net product revenues and services revenues. A rise in operating income bodes well for...

KBR's fourth-quarter 2024 results reflect strong contributions from its GS and STS segments and benefits from the LinQuest acquisition.

SoundHound's fourth-quarter 2024 results reflect record y/y growth in revenues and AI innovation. Soaring expenses spark concerns.

Catalyst stock gains on strong fourth-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse sales.

PHG's fourth-quarter results reflect a decline in sales and earnings due to weaker demand in China, leading to lowered 2025 guidance and a cautious...

Vir Biotechnology (VIR) delivered earnings and revenue surprises of 10.59% and 15.22%, respectively, for the quarter ended December 2024. Do the...

TFX benefits from a diversified product portfolio in the fourth quarter of 2024, with strength in the Surgical and Interventional segments.